 | • レポートコード：QYR2104Z2051 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、EGFR変異試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（DNA配列、キット）、用途別市場規模（がん病院、臨床研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・EGFR変異試験の市場動向 ・企業の競争状況、市場シェア ・EGFR変異試験の種類別市場規模（DNA配列、キット） ・EGFR変異試験の用途別市場規模（がん病院、臨床研究所） ・EGFR変異試験の北米市場規模2016-2027（アメリカ、カナダ） ・EGFR変異試験のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・EGFR変異試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・EGFR変異試験の中南米市場規模2016-2027（メキシコ、ブラジル） ・EGFR変異試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Merck、Thermo Fisher Scientific、Illumina、BioMerieux、QIAGEN、Agilent Technologies、Hologic、Novartis、Roche、Genomic Health） ・結論 |
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
Market Analysis and Insights: Global EGFR Mutation Test Market
The global EGFR Mutation Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global EGFR Mutation Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global EGFR Mutation Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global EGFR Mutation Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global EGFR Mutation Test market.
Global EGFR Mutation Test Scope and Market Size
EGFR Mutation Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global EGFR Mutation Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
DNA Sequencing
Kits
Segment by Application
Cancer Hospitals
Clinical Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EGFR Mutation Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DNA Sequencing
1.2.3 Kits
1.3 Market by Application
1.3.1 Global EGFR Mutation Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Hospitals
1.3.3 Clinical Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global EGFR Mutation Test Market Perspective (2016-2027)
2.2 EGFR Mutation Test Growth Trends by Regions
2.2.1 EGFR Mutation Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 EGFR Mutation Test Historic Market Share by Regions (2016-2021)
2.2.3 EGFR Mutation Test Forecasted Market Size by Regions (2022-2027)
2.3 EGFR Mutation Test Industry Dynamic
2.3.1 EGFR Mutation Test Market Trends
2.3.2 EGFR Mutation Test Market Drivers
2.3.3 EGFR Mutation Test Market Challenges
2.3.4 EGFR Mutation Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top EGFR Mutation Test Players by Revenue
3.1.1 Global Top EGFR Mutation Test Players by Revenue (2016-2021)
3.1.2 Global EGFR Mutation Test Revenue Market Share by Players (2016-2021)
3.2 Global EGFR Mutation Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by EGFR Mutation Test Revenue
3.4 Global EGFR Mutation Test Market Concentration Ratio
3.4.1 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EGFR Mutation Test Revenue in 2020
3.5 EGFR Mutation Test Key Players Head office and Area Served
3.6 Key Players EGFR Mutation Test Product Solution and Service
3.7 Date of Enter into EGFR Mutation Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 EGFR Mutation Test Breakdown Data by Type
4.1 Global EGFR Mutation Test Historic Market Size by Type (2016-2021)
4.2 Global EGFR Mutation Test Forecasted Market Size by Type (2022-2027)
5 EGFR Mutation Test Breakdown Data by Application
5.1 Global EGFR Mutation Test Historic Market Size by Application (2016-2021)
5.2 Global EGFR Mutation Test Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America EGFR Mutation Test Market Size (2016-2027)
6.2 North America EGFR Mutation Test Market Size by Type
6.2.1 North America EGFR Mutation Test Market Size by Type (2016-2021)
6.2.2 North America EGFR Mutation Test Market Size by Type (2022-2027)
6.2.3 North America EGFR Mutation Test Market Size by Type (2016-2027)
6.3 North America EGFR Mutation Test Market Size by Application
6.3.1 North America EGFR Mutation Test Market Size by Application (2016-2021)
6.3.2 North America EGFR Mutation Test Market Size by Application (2022-2027)
6.3.3 North America EGFR Mutation Test Market Size by Application (2016-2027)
6.4 North America EGFR Mutation Test Market Size by Country
6.4.1 North America EGFR Mutation Test Market Size by Country (2016-2021)
6.4.2 North America EGFR Mutation Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe EGFR Mutation Test Market Size (2016-2027)
7.2 Europe EGFR Mutation Test Market Size by Type
7.2.1 Europe EGFR Mutation Test Market Size by Type (2016-2021)
7.2.2 Europe EGFR Mutation Test Market Size by Type (2022-2027)
7.2.3 Europe EGFR Mutation Test Market Size by Type (2016-2027)
7.3 Europe EGFR Mutation Test Market Size by Application
7.3.1 Europe EGFR Mutation Test Market Size by Application (2016-2021)
7.3.2 Europe EGFR Mutation Test Market Size by Application (2022-2027)
7.3.3 Europe EGFR Mutation Test Market Size by Application (2016-2027)
7.4 Europe EGFR Mutation Test Market Size by Country
7.4.1 Europe EGFR Mutation Test Market Size by Country (2016-2021)
7.4.2 Europe EGFR Mutation Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific EGFR Mutation Test Market Size (2016-2027)
8.2 Asia-Pacific EGFR Mutation Test Market Size by Type
8.2.1 Asia-Pacific EGFR Mutation Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific EGFR Mutation Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific EGFR Mutation Test Market Size by Type (2016-2027)
8.3 Asia-Pacific EGFR Mutation Test Market Size by Application
8.3.1 Asia-Pacific EGFR Mutation Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific EGFR Mutation Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific EGFR Mutation Test Market Size by Application (2016-2027)
8.4 Asia-Pacific EGFR Mutation Test Market Size by Region
8.4.1 Asia-Pacific EGFR Mutation Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific EGFR Mutation Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America EGFR Mutation Test Market Size (2016-2027)
9.2 Latin America EGFR Mutation Test Market Size by Type
9.2.1 Latin America EGFR Mutation Test Market Size by Type (2016-2021)
9.2.2 Latin America EGFR Mutation Test Market Size by Type (2022-2027)
9.2.3 Latin America EGFR Mutation Test Market Size by Type (2016-2027)
9.3 Latin America EGFR Mutation Test Market Size by Application
9.3.1 Latin America EGFR Mutation Test Market Size by Application (2016-2021)
9.3.2 Latin America EGFR Mutation Test Market Size by Application (2022-2027)
9.3.3 Latin America EGFR Mutation Test Market Size by Application (2016-2027)
9.4 Latin America EGFR Mutation Test Market Size by Country
9.4.1 Latin America EGFR Mutation Test Market Size by Country (2016-2021)
9.4.2 Latin America EGFR Mutation Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa EGFR Mutation Test Market Size (2016-2027)
10.2 Middle East & Africa EGFR Mutation Test Market Size by Type
10.2.1 Middle East & Africa EGFR Mutation Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa EGFR Mutation Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa EGFR Mutation Test Market Size by Type (2016-2027)
10.3 Middle East & Africa EGFR Mutation Test Market Size by Application
10.3.1 Middle East & Africa EGFR Mutation Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa EGFR Mutation Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa EGFR Mutation Test Market Size by Application (2016-2027)
10.4 Middle East & Africa EGFR Mutation Test Market Size by Country
10.4.1 Middle East & Africa EGFR Mutation Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa EGFR Mutation Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott EGFR Mutation Test Introduction
11.1.4 Abbott Revenue in EGFR Mutation Test Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck EGFR Mutation Test Introduction
11.2.4 Merck Revenue in EGFR Mutation Test Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific EGFR Mutation Test Introduction
11.3.4 Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina EGFR Mutation Test Introduction
11.4.4 Illumina Revenue in EGFR Mutation Test Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux EGFR Mutation Test Introduction
11.5.4 BioMerieux Revenue in EGFR Mutation Test Business (2016-2021)
11.5.5 BioMerieux Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN EGFR Mutation Test Introduction
11.6.4 QIAGEN Revenue in EGFR Mutation Test Business (2016-2021)
11.6.5 QIAGEN Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies EGFR Mutation Test Introduction
11.7.4 Agilent Technologies Revenue in EGFR Mutation Test Business (2016-2021)
11.7.5 Agilent Technologies Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic EGFR Mutation Test Introduction
11.8.4 Hologic Revenue in EGFR Mutation Test Business (2016-2021)
11.8.5 Hologic Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis EGFR Mutation Test Introduction
11.9.4 Novartis Revenue in EGFR Mutation Test Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche EGFR Mutation Test Introduction
11.10.4 Roche Revenue in EGFR Mutation Test Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Genomic Health
11.11.1 Genomic Health Company Details
11.11.2 Genomic Health Business Overview
11.11.3 Genomic Health EGFR Mutation Test Introduction
11.11.4 Genomic Health Revenue in EGFR Mutation Test Business (2016-2021)
11.11.5 Genomic Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global EGFR Mutation Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DNA Sequencing
Table 3. Key Players of Kits
Table 4. Global EGFR Mutation Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global EGFR Mutation Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global EGFR Mutation Test Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global EGFR Mutation Test Market Share by Regions (2016-2021)
Table 8. Global EGFR Mutation Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global EGFR Mutation Test Market Share by Regions (2022-2027)
Table 10. EGFR Mutation Test Market Trends
Table 11. EGFR Mutation Test Market Drivers
Table 12. EGFR Mutation Test Market Challenges
Table 13. EGFR Mutation Test Market Restraints
Table 14. Global EGFR Mutation Test Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global EGFR Mutation Test Market Share by Players (2016-2021)
Table 16. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EGFR Mutation Test as of 2020)
Table 17. Ranking of Global Top EGFR Mutation Test Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by EGFR Mutation Test Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players EGFR Mutation Test Product Solution and Service
Table 21. Date of Enter into EGFR Mutation Test Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global EGFR Mutation Test Market Size by Type (2016-2021) (US$ Million)
Table 24. Global EGFR Mutation Test Revenue Market Share by Type (2016-2021)
Table 25. Global EGFR Mutation Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global EGFR Mutation Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global EGFR Mutation Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global EGFR Mutation Test Revenue Market Share by Application (2016-2021)
Table 29. Global EGFR Mutation Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global EGFR Mutation Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America EGFR Mutation Test Market Size by Type (2016-2021) (US$ Million)
Table 32. North America EGFR Mutation Test Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America EGFR Mutation Test Market Size by Application (2016-2021) (US$ Million)
Table 34. North America EGFR Mutation Test Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America EGFR Mutation Test Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America EGFR Mutation Test Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe EGFR Mutation Test Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe EGFR Mutation Test Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe EGFR Mutation Test Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe EGFR Mutation Test Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe EGFR Mutation Test Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe EGFR Mutation Test Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific EGFR Mutation Test Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific EGFR Mutation Test Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific EGFR Mutation Test Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific EGFR Mutation Test Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific EGFR Mutation Test Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific EGFR Mutation Test Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America EGFR Mutation Test Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America EGFR Mutation Test Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America EGFR Mutation Test Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America EGFR Mutation Test Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America EGFR Mutation Test Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America EGFR Mutation Test Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa EGFR Mutation Test Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa EGFR Mutation Test Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa EGFR Mutation Test Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa EGFR Mutation Test Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa EGFR Mutation Test Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa EGFR Mutation Test Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott EGFR Mutation Test Product
Table 64. Abbott Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck EGFR Mutation Test Product
Table 69. Merck Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific EGFR Mutation Test Product
Table 74. Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Illumina Company Details
Table 77. Illumina Business Overview
Table 78. Illumina EGFR Mutation Test Product
Table 79. Illumina Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 80. Illumina Recent Development
Table 81. BioMerieux Company Details
Table 82. BioMerieux Business Overview
Table 83. BioMerieux EGFR Mutation Test Product
Table 84. BioMerieux Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 85. BioMerieux Recent Development
Table 86. QIAGEN Company Details
Table 87. QIAGEN Business Overview
Table 88. QIAGEN EGFR Mutation Test Product
Table 89. QIAGEN Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 90. QIAGEN Recent Development
Table 91. Agilent Technologies Company Details
Table 92. Agilent Technologies Business Overview
Table 93. Agilent Technologies EGFR Mutation Test Product
Table 94. Agilent Technologies Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 95. Agilent Technologies Recent Development
Table 96. Hologic Company Details
Table 97. Hologic Business Overview
Table 98. Hologic Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 99. Hologic Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis EGFR Mutation Test Product
Table 103. Novartis Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 104. Novartis Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche EGFR Mutation Test Product
Table 108. Roche Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Genomic Health Company Details
Table 111. Genomic Health Business Overview
Table 112. Genomic Health EGFR Mutation Test Product
Table 113. Genomic Health Revenue in EGFR Mutation Test Business (2016-2021) & (US$ Million)
Table 114. Genomic Health Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global EGFR Mutation Test Market Share by Type: 2020 VS 2027
Figure 2. DNA Sequencing Features
Figure 3. Kits Features
Figure 4. Global EGFR Mutation Test Market Share by Application: 2020 VS 2027
Figure 5. Cancer Hospitals Case Studies
Figure 6. Clinical Research Institutes Case Studies
Figure 7. EGFR Mutation Test Report Years Considered
Figure 8. Global EGFR Mutation Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global EGFR Mutation Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global EGFR Mutation Test Market Share by Regions: 2020 VS 2027
Figure 11. Global EGFR Mutation Test Market Share by Regions (2022-2027)
Figure 12. Global EGFR Mutation Test Market Share by Players in 2020
Figure 13. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EGFR Mutation Test as of 2020
Figure 14. The Top 10 and 5 Players Market Share by EGFR Mutation Test Revenue in 2020
Figure 15. Global EGFR Mutation Test Revenue Market Share by Type (2016-2021)
Figure 16. Global EGFR Mutation Test Revenue Market Share by Type (2022-2027)
Figure 17. North America EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America EGFR Mutation Test Market Share by Type (2016-2027)
Figure 19. North America EGFR Mutation Test Market Share by Application (2016-2027)
Figure 20. North America EGFR Mutation Test Market Share by Country (2016-2027)
Figure 21. United States EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe EGFR Mutation Test Market Share by Type (2016-2027)
Figure 25. Europe EGFR Mutation Test Market Share by Application (2016-2027)
Figure 26. Europe EGFR Mutation Test Market Share by Country (2016-2027)
Figure 27. Germany EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific EGFR Mutation Test Market Share by Type (2016-2027)
Figure 35. Asia-Pacific EGFR Mutation Test Market Share by Application (2016-2027)
Figure 36. Asia-Pacific EGFR Mutation Test Market Share by Region (2016-2027)
Figure 37. China EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America EGFR Mutation Test Market Share by Type (2016-2027)
Figure 45. Latin America EGFR Mutation Test Market Share by Application (2016-2027)
Figure 46. Latin America EGFR Mutation Test Market Share by Country (2016-2027)
Figure 47. Mexico EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa EGFR Mutation Test Market Share by Type (2016-2027)
Figure 51. Middle East & Africa EGFR Mutation Test Market Share by Application (2016-2027)
Figure 52. Middle East & Africa EGFR Mutation Test Market Share by Country (2016-2027)
Figure 53. Turkey EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE EGFR Mutation Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 57. Merck Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 59. Illumina Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 60. BioMerieux Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 61. QIAGEN Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 62. Agilent Technologies Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 63. Hologic Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 66. Genomic Health Revenue Growth Rate in EGFR Mutation Test Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の突然変異生成システム市場規模・現状・予測（2021年-2027年） The mutation generation system is used for the functional analysis of the proteins. The mutation generation system enables the saturated libraries of transformed proteins in a response within a very less duration of time. The mutation generation system is a complete package of reagents for transposo…- 世界の高度NSCLC用EGFR-TKI市場規模・現状・予測（2021年-2027年） EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations. Market Analysis and Insights: Global EGFR-TKI for Advanced NSCLC Market The global EGFR-TKI for Advanced…
- 世界の高度NSCLC用EGFR-TKI市場規模・現状・予測（2021年-2027年） EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations. Market Analysis and Insights: Global EGFR-TKI for Advanced NSCLC Market The global EGFR-TKI for Advanced…
- 世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の甲状腺ホーム検査キット市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Home Test Kits Market The global Thyroid Home Test Kits market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…